(CLS) Celestica - Overview

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA15101Q2071

Stock: Manufacturing, Assembly, Testing, Logistics, Repair

Total Rating 86

Risk 88

Buy Signal -1.13

Electronic Components » Electronic Manufacturing Services
Age: 27.6y

Market Cap: 32,414m
Avg Trading Vol: 819M USD

ATR: 8.75%
Peers RS (IBD): 78.57

EPS (Earnings per Share)

EPS CAGR: 52.33%
EPS Trend: 98.6%

Last SUE: 4.00
Qual. Beats: 11

Revenue

Rev. CAGR: 25.85%
Rev. Trend: 96.6%

Last SUE: 4.00
Qual. Beats: 4

Risk 5d forecast
Volatility	85.2%
Relative Tail Risk	-1.02%

Reward TTM
Sharpe Ratio	1.45
Alpha	119.11

Character TTM
Beta	2.179
Beta Downside	2.108

Drawdowns 3y
Max DD	53.96%
CAGR/Max DD	3.31

Description: CLS Celestica December 17, 2025

Celestica Inc. (NYSE:CLS) is a Toronto-based provider of end-to-end supply-chain and manufacturing services, operating globally across Asia, North America and other regions. The firm serves original equipment manufacturers (OEMs) and cloud-centric service providers, delivering design-to-delivery capabilities that span product development, component sourcing, electronics manufacturing, testing, systems integration, logistics, and after-market support.

Its operations are organized into two segments: Advanced Technology Solutions, which focuses on high-mix, high-value manufacturing for aerospace & defense, industrial equipment, and HealthTech; and Connectivity & Cloud Solutions, which targets hyperscalers, communications, and enterprise cloud infrastructure providers. The company also offers hardware platform services, including open-source software customization and IT asset disposition.

Key performance indicators from FY 2023 show $5.1 billion in revenue, a 4.2 % operating margin, and double-digit growth in the Connectivity & Cloud segment driven by rising demand for data-center hardware and semiconductor shortages that have heightened the value of resilient supply-chain partners. Macro-level drivers include the global shift toward cloud computing, increased defense spending, and the ongoing re-shoring of critical electronics manufacturing.

For a deeper quantitative view, explore the ValueRay dashboard for CLS’s valuation metrics and scenario analysis.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income: 833.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.10 > 1.0
NWC/Revenue: 13.94% < 20% (prev 15.46%; Δ -1.51% < -1%)
CFO/TA 0.09 > 3% & CFO 661.9m > Net Income 833.6m
Net Debt (180.6m) to EBITDA (1.21b): 0.15 < 3
Current Ratio: 1.44 > 1.5 & < 3
Outstanding Shares: last quarter (115.9m) vs 12m ago -1.19% < -2%
Gross Margin: 11.60% > 18% (prev 0.11%; Δ 1149 % > 0.5%)
Asset Turnover: 188.2% > 50% (prev 161.1%; Δ 27.14% > 0%)
Interest Coverage Ratio: 19.70 > 6 (EBITDA TTM 1.21b / Interest Expense TTM 52.7m)

Altman Z'' 3.16

A: 0.24 (Total Current Assets 5.66b - Total Current Liabilities 3.93b) / Total Assets 7.20b
B: 0.02 (Retained Earnings 141.1m / Total Assets 7.20b)
C: 0.16 (EBIT TTM 1.04b / Avg Total Assets 6.59b)
D: 0.44 (Book Value of Equity 2.21b / Total Liabilities 4.99b)
Altman-Z'' Score: 3.16 = A

Beneish M -2.97

DSRI: 0.99 (Receivables 2.63b/2.07b, Revenue 12.41b/9.65b)
GMI: 0.92 (GM 11.60% / 10.62%)
AQI: 0.85 (AQ_t 0.12 / AQ_t-1 0.14)
SGI: 1.29 (Revenue 12.41b / 9.65b)
TATA: 0.02 (NI 833.6m - CFO 661.9m) / TA 7.20b)
Beneish M-Score: -2.97 (Cap -4..+1) = A

What is the price of CLS shares?

As of February 03, 2026, the stock is trading at USD 285.11 with a total of 4,249,100 shares traded.
Over the past week, the price has changed by -7.51%, over one month by -5.72%, over three months by -18.31% and over the past year by +135.86%.

Is CLS a buy, sell or hold?

Celestica has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy CLS.

StrongBuy: 6
Buy: 6
Hold: 1
Sell: 0
StrongSell: 0

What are the forecasts/targets for the CLS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	382.4	34.1%
Analysts Target Price	382.4	34.1%
ValueRay Target Price	421.2	47.7%

CLS Fundamental Data Overview February 03, 2026

P/E Trailing = 39.1897
P/E Forward = 33.557
P/S = 2.616
P/B = 14.5674
P/EG = 19.42
Revenue TTM = 12.41b USD
EBIT TTM = 1.04b USD
EBITDA TTM = 1.21b USD
Long Term Debt = 750.5m USD (from longTermDebt, last quarter)
Short Term Debt = 26.0m USD (from shortTermDebt, last quarter)
Debt = 775.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 180.6m USD (from netDebt column, last quarter)
Enterprise Value = 32.59b USD (32.41b + Debt 775.1m - CCE 595.6m)
Interest Coverage Ratio = 19.70 (Ebit TTM 1.04b / Interest Expense TTM 52.7m)
EV/FCF = 70.93x (Enterprise Value 32.59b / FCF TTM 459.5m)
FCF Yield = 1.41% (FCF TTM 459.5m / Enterprise Value 32.59b)
FCF Margin = 3.70% (FCF TTM 459.5m / Revenue TTM 12.41b)
Net Margin = 6.72% (Net Income TTM 833.6m / Revenue TTM 12.41b)
Gross Margin = 11.60% ((Revenue TTM 12.41b - Cost of Revenue TTM 10.97b) / Revenue TTM)
Gross Margin QoQ = 11.52% (prev 11.62%)
Tobins Q-Ratio = 4.53 (Enterprise Value 32.59b / Total Assets 7.20b)
Interest Expense / Debt = 1.65% (Interest Expense 12.8m / Debt 775.1m)
Taxrate = 11.22% (34.3m / 305.9m)
NOPAT = 920.7m (EBIT 1.04b * (1 - 11.22%))
Current Ratio = 1.44 (Total Current Assets 5.66b / Total Current Liabilities 3.93b)
Debt / Equity = 0.35 (Debt 775.1m / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 0.15 (Net Debt 180.6m / EBITDA 1.21b)
Debt / FCF = 0.39 (Net Debt 180.6m / FCF TTM 459.5m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.64% (Net Income 833.6m / Total Assets 7.20b)
RoE = 44.13% (Net Income TTM 833.6m / Total Stockholder Equity 1.89b)
RoCE = 39.29% (EBIT 1.04b / Capital Employed (Equity 1.89b + L.T.Debt 750.5m))
RoIC = 34.77% (NOPAT 920.7m / Invested Capital 2.65b)
WACC = 13.65% (E(32.41b)/V(33.19b) * Re(13.94%) + D(775.1m)/V(33.19b) * Rd(1.65%) * (1-Tc(0.11)))
Discount Rate = 13.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.52%
[DCF Debug] Terminal Value 65.08% ; FCFF base≈378.3m ; Y1≈466.7m ; Y5≈794.8m
Fair Price DCF = 52.10 (EV 6.17b - Net Debt 180.6m = Equity 5.99b / Shares 114.9m; r=13.65% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 98.64 | EPS CAGR: 52.33% | SUE: 4.0 | # QB: 11
Revenue Correlation: 96.61 | Revenue CAGR: 25.85% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-03-31): EPS=2.08 | Chg30d=+0.260 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=8.99 | Chg30d=+0.573 | Revisions Net=-1 | Growth EPS=+48.6% | Growth Revenue=+40.3%
EPS next Year (2027-12-31): EPS=12.84 | Chg30d=+1.030 | Revisions Net=+0 | Growth EPS=+42.8% | Growth Revenue=+38.0%

Additional Sources for CLS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle